Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine

DOI: 10.1186/s12935-019-0894-y

Keywords: MiR-29c expression, Acute myeloid leukemia, Prognostic, Decitabine

Full-Text   Cite this paper   Add to My Lib

Abstract:

The online version of this article (10.1186/s12935-019-0894-y) contains supplementary material, which is available to authorized users

Full-Text